IGC Pharma (IGC) Net Income Growth (3y) (2013 - 2025)
IGC Pharma (IGC) Net Income Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
30.59% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
19.97% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
9.32% |
| Jun 30, 2025 |
16.89% |
| Mar 31, 2025 |
43.10% |
| Dec 31, 2024 |
8.42% |
| Sep 30, 2024 |
26.61% |
| Jun 30, 2024 |
-9.97% |
| Mar 31, 2024 |
0.73% |
| Dec 31, 2023 |
-34.00% |
| Sep 30, 2023 |
-13.94% |
| Jun 30, 2023 |
-3.31% |
| Mar 31, 2023 |
-8.51% |
| Dec 31, 2022 |
-11.95% |
| Sep 30, 2022 |
-27.47% |
| Jun 30, 2022 |
-26.40% |
| Mar 31, 2022 |
-60.33% |
| Dec 31, 2021 |
-27.53% |
| Sep 30, 2021 |
-71.65% |
| Jun 30, 2021 |
-51.72% |
| Mar 31, 2021 |
-72.51% |
| Dec 31, 2020 |
-63.36% |
